A

Researcher Profile

Andrew Wiznia

3

Publications

153

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article The Lancet HIV Aug 01, 2023

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

Onyema Ogbuagu · Sorana Segal-Maurer · Winai Ratanasuwan · Anchalee Avihingsanon +43 more

10.1016/s2352-3018(23)00113-3 65 citations

Open Access Journal Article The Lancet HIV May 01, 2022

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

Theodore D Ruel · Edward P Acosta · Jessica P Liu · Kathryn P Gray +64 more

10.1016/s2352-3018(22)00044-3 33 citations

Journal Article The Journal of Infectious Diseases Nov 04, 2019

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

Coleen K Cunningham · Elizabeth J McFarland · R Leavitt Morrison · Edmund V Capparelli +62 more

10.1093/infdis/jiz532 55 citations

Publication Timeline

2023

1

2022

1

2019

1

Frequent Co-Authors

Michele F Carter

Jaime G Deville

Mahboobullah Mirza Baig

R Leavitt Morrison

Takuma Shirasaka

Kenneth Lichtenstein